Design of the DAVOS Study: Diabetes Smartphone App, a Fully Automatic Transmission of Data From the Blood Glucose Meter and Insulin Pens Using Wireless Technology to Enhance Diabetes Self-Management—A Study Protocol for a Randomized Controlled Trial
Study context
- Population
- Insulin-treated diabetes patients aged ≥18planned recruitment
- Participants
- 154 patients
- Planned comparison
- Diabetes app plus standard care vs standard care
- Primary endpoint
- Overall reduction of HbA1c
Methodological detailsprospective, multicentric, 6-month, Conducted per International Conference on Harmonization-Good Clinical Practice (ICH-GCP) Guidelines, HbA1c monitored at three defined visits; secondary endpoints (eg, app usability) by patient-reported outcome questionnaires
- Prospective
- Multicentric
- 6-month
- Conducted per ICH-GCP Guidelines
- HbA1c monitored at three defined visits; secondary endpoints (eg, app usability) by patient-reported outcome questionnaires
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
Design of the DAVOS Study: Diabetes Smartphone App, a Fully Automatic Transmission of Data From the Blood Glucose Meter and Insulin Pens Using Wireless Technology to Enhance Diabetes Self-Management—A Study Protocol for a Randomized Controlled Trial. J Diabetes Sci Technol. Published 8 April 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →